A plasmid is a small, circular, double-stranded DNA molecule that is distinct from a cell's chromosomal DNA. Plasmids naturally exist in bacterial cells, and they also occur in some eukaryotes.
13d
Clinical Trials Arena on MSNImunon reports immunogenicity and safety data from DNA plasmid vaccine trialImunon has reported new immunogenicity and safety data from its proof-of-concept Phase I trial’s ongoing analyses of the IMNN ...
The ability to control gene expression across a wide range is crucial for many fields, including bioengineering, disease ...
Price drop reflects efficiency gains from Co.’s cell-free cloning tech & new facility, where automation & ML have increased ...
Plasmids come in different sizes and conformations, and so confirming and verifying plasmid quality is essential for downstream use. Scientists commonly do this using gel electrophoresis analysis, ...
Results of IMNN-101 Proof-of-Concept study demonstrate persistent immunogenicity in trial participants and further validate PlaCCine® ...
A scaleable method for the liquid-phase separation of plasmid DNA from RNA. In the course of experiments on the potential of nucleic acid compaction for enhancement of chromatographic adsorption ...
Discover the price reduction of ENFINIA™ DNA products by 25%, improving access to high-quality DNA for researchers.
Zydus Cadila has filed for emergency use approval (EUA) in India of its plasmid DNA-based vaccine for COVID-19, which if given a green light could become the first shot of its type to be cleared ...
coli expression system. It serves as a comprehensive solution for the development and manufacturing of non-monoclonal antibody (non-mAb) recombinant proteins and plasmid DNA for clients across the ...
Imunon has reported new immunogenicity and safety data from its proof-of-concept Phase I trial’s ongoing analyses of the IMNN-101 DNA plasmid vaccine. The investigational vaccine, based on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results